Grandeur Peak Global Explorer Fund Launch December 16, 2021
Please see below for today’s Press Release announcing the launch of the Grandeur Peak Global Explorer Fund (GPGEX) on Thursday, December 16, 2021.
The Global Explorer Fund will only be available in one share class (Institutional), with a minimum investment of just $1,000 ($100 for minors)* in order to make it broadly accessible to all investors. The Fund should be available through most of our existing channel relationships (Schwab, TD Ameritrade, Pershing, Fidelity, etc.) and it is of course available directly from Grandeur Peak Funds. If you have difficulty purchasing the Fund, please let us know and we will work with you to try to get it listed on your platform.
To learn more about this new fund, call any of us on the client team (contacts below) or our Investor Services team at 1-855-377-7325; Additional information will also be posted to our website: www.grandeurpeakglobal.com.
Best Regards,
Mark Siddoway, CFA, CAIA, MBA
Head of Client Relations
801-384-0010
Todd Matheny, CAIA
Director of Client Relations
801-384-0095
Amy Johnson, MBA, CFP®
Sr. Manager, Client Relations
801-384-0044
*Third-party platforms may impose different minimum requirements.
PRESS RELEASE
Dear Fellow Shareholders,
We are pleased to announce the launch of the Grandeur Peak Global Explorer Fund (GPGEX). The Fund will invest in what the firm believes are the most interesting equity investments around the world. The holdings will primarily be micro to mid-cap companies.
The new fund is a sister fund to the existing Grandeur Peak Global Reach Fund (GPRIX). The two funds share a similar mandate, but they approach portfolio management from a different angle. The Global Reach Fund (launched in 2013) is managed collaboratively by the firm’s five industry teams/portfolio managers, plus a guardian portfolio manager. Similarly, the new Global Explorer Fund will be managed by the firm’s seven geographic region teams/portfolio managers, plus a guardian portfolio manager.
Said Blake Walker, CEO, “In our quest to cover the globe, members of our research team wear multiple hats – some combination of an industry hat, a geography hat, and a fund hat. We long ago divided the world up into industries (5) and geographic regions (7) and gave analysts the charge to find the most interesting companies in their assigned space. The beauty of viewing the world through these two different lenses is that we have at least two people looking at every company, namely the relevant industry analyst and geography analyst. We have found it to be a powerful ‘multiple minds’ tool.”
Juliette Douglas, a geography portfolio manager, and the portfolio manager who will coordinate the Global Explorer team’s efforts, continued, “In hindsight, it could have made sense to launch the Global Explorer at the same time as Global Reach, but candidly we weren’t staffed or ready to do so eight years ago. Today it’s an easy extension for our team and the geographic paper portfolio we have managed for some time. We expect Reach and Explorer will look fairly similar given our collaborative approach, but we also believe there will be a very real benefit in putting our geography PMs at the helm of their own fund. Those benefits will play out in the Global Explorer Fund and also radiate through the rest of the Grandeur Peak Funds. The geography teams are thrilled at this opportunity.”
Grandeur Peak has from day one shown a very strong commitment to managing capacity at a firm level, and closing funds early. With many of the Grandeur Peak Funds currently closed, Todd Matheny, Director of Client Relations, commented on the capacity of the new Fund: “With the Global Explorer Fund focused on our more capacity-constrained micro to mid-cap space, we plan to soft close the Fund around $35M in AUM. We are excited about this Fund, and the strategic value it adds across our entire family of funds, but we intend to close it very small to ensure all of our funds retain the investment flexibility they need to remain focused on delivering performance for our clients.”
VHCOX lost its' touch? As a long term owner of two Primecap funds (at either end of the so-called risk spectrum) I have some concerns. The obvious one is relative performance: all of the Primecap funds seem to have under-performed their benchmarks -- as well as "the market" -- over the past five years, some over the past ten (especially when taxes are taken into account). I regard that as a moderate length of time, sufficient to capture my attention. When it comes to the riskier funds (in my case POAGX), I seem to see some very off-beat names in the top 25 holdings, although I'm certainly not privy to the research resulting in those buy decisions. Of far greater concern to me is the fact that the team at Primecap appears to lack any notion of a "sell" discipline. The concept of a "target price" seems alien to them. On many occasions in the recent past the market has literally gifted stocks in the portfolios with sudden, unwarranted, and ultimately temporary price increases that Primecap rarely takes advantage of. (Examples include BABA, BIIB, NKTR, SGEN, but there are quite a few in addition.) What to do? I decided to take this year's hefty capital gains distributions (attributable to shareholder redemptions) in cash. Based on preliminary information, it looks like most Odyssey fund shareholders did the same thing yesterday. The Vanguard funds haven't made their distributions yet.
Best Biotech Fund? PRHSX held 29.3% of its 200 name portfolio in biotech as of 09-30-2021.
I've owned the fund for a long time, and the key to me has been to buy it and forget it. An investment in a health sector fund is definitely a long term (10+ years) prospect.